MMP2 expression is a prognostic marker for primary melanoma patients.
about
Role of Matrix Metalloproteinases in Photoaging and PhotocarcinogenesisMelanoma Brain Metastasis: Mechanisms, Models, and MedicineEvaluating biomarkers in melanoma.Stage-specific prognostic biomarkers in melanomaFad104, a positive regulator of adipocyte differentiation, suppresses invasion and metastasis of melanoma cells by inhibition of STAT3 activity.Multifunctional bioscaffolds for 3D culture of melanoma cells reveal increased MMP activity and migration with BRAF kinase inhibition.Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.Protein kinase C inhibitor Gö6976 but not Gö6983 induces the reversion of E- to N-cadherin switch and metastatic phenotype in melanoma: identification of the role of protein kinase D1A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion.Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.Construction and analysis of multiparameter prognostic models for melanoma outcomeS100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer.Protein and non-protein biomarkers in melanoma: a critical update.Melanoma biomolecules: independently identified but functionally intertwined.Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion.Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.Prognostic significance of the expression of nuclear eukaryotic translation initiation factor 5A2 in human melanoma.Astrocytes facilitate melanoma brain metastasis via secretion of IL-23.Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
P2860
Q26748463-772582D0-8FDD-4727-9357-5B2920D49927Q28069421-2703F0A2-0E22-4FC3-A0D9-CBCD0A24AEF8Q35005677-C1BD9CB9-B820-4B8A-9972-9001222F3BD0Q35551970-AE53654A-559B-4333-9BF0-C97876968D2AQ35559300-FE130C9D-2826-4452-8B8B-181EFE3BB36AQ35567027-44EDC4E0-6538-4CE8-8436-F279709F1548Q35728896-DD73F586-A220-4A43-B6A9-5F4681A01D65Q36240981-3A26F490-4AFD-4B59-B98A-9267621B83ABQ36262832-FAE64092-FA19-4D86-88E3-1B8ADFCC4BB3Q36356155-857B6DC8-007E-4380-B1BC-EB38AF1970A4Q36413212-DED8A056-E4A7-4A44-BB3F-7C7A7004DF0EQ36616174-50C7FEF1-63F8-4A4B-8DB5-141674361B2CQ37550749-12341A3F-AFAD-4BBD-9E05-B007E3131827Q37660289-C30FA3F9-FD02-4E8D-820C-9E6A72BECA0EQ38050990-5EAFA4D9-7FE3-4019-9E22-9DF863E60320Q38143977-09BDE47B-E1D3-44FF-ADE5-935AD6434774Q38673407-6785BB0A-D39C-44B7-A334-1BF90BAFD45EQ39068047-DFD1CDFD-1F79-44DC-952F-FB8602062A2AQ42021143-968DD1ED-6BA6-4C45-8F5F-C8120A817E30Q42031208-1C79E26D-CEE3-465F-930B-1498250D4CEDQ48350672-326C06DB-B72B-425C-B618-995BA626D0F5Q49735252-9A710E13-1AB4-40F0-B8F5-A6D7D3F3E3A4
P2860
MMP2 expression is a prognostic marker for primary melanoma patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
MMP2 expression is a prognostic marker for primary melanoma patients.
@en
MMP2 expression is a prognostic marker for primary melanoma patients.
@nl
type
label
MMP2 expression is a prognostic marker for primary melanoma patients.
@en
MMP2 expression is a prognostic marker for primary melanoma patients.
@nl
prefLabel
MMP2 expression is a prognostic marker for primary melanoma patients.
@en
MMP2 expression is a prognostic marker for primary melanoma patients.
@nl
P2860
P1433
P1476
MMP2 expression is a prognostic marker for primary melanoma patients
@en
P2093
Magdalena Martinka
P2860
P2888
P304
P356
10.1007/S13402-012-0080-X
P50
P577
2012-06-06T00:00:00Z